News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,038 Results
Type
Article (39303)
Company Profile (247)
Press Release (651488)
Section
Business (203984)
Career Advice (2002)
Deals (35400)
Drug Delivery (89)
Drug Development (80916)
Employer Resources (169)
FDA (16123)
Job Trends (14820)
News (344804)
Policy (32468)
Tag
Academia (2531)
Alliances (49290)
Alzheimer's disease (1300)
Approvals (16092)
Artificial intelligence (183)
Bankruptcy (354)
Best Places to Work (11624)
Biotechnology (175)
Breast cancer (216)
Cancer (1603)
Cardiovascular disease (123)
Career advice (1668)
Cell therapy (324)
Clinical research (65075)
Collaboration (614)
Compensation (332)
COVID-19 (2556)
C-suite (142)
Data (1518)
Diabetes (197)
Diagnostics (6238)
Earnings (85149)
Employer resources (146)
Events (110572)
Executive appointments (529)
FDA (16949)
Funding (559)
Gene therapy (224)
GLP-1 (636)
Government (4351)
Healthcare (18743)
Infectious disease (2658)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16427)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7878)
Lung cancer (238)
Manufacturing (223)
Medical device (13246)
Medtech (13251)
Mergers & acquisitions (19290)
Metabolic disorders (518)
Neuroscience (1686)
NextGen: Class of 2025 (6508)
Non-profit (4474)
Northern California (1941)
Obesity (294)
Opinion (190)
Parkinson's disease (113)
Patents (138)
People (56733)
Phase I (20262)
Phase II (28662)
Phase III (21347)
Pipeline (648)
Postmarket research (2562)
Preclinical (8562)
Radiopharmaceuticals (240)
Rare diseases (304)
Real estate (5894)
Regulatory (21840)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1679)
Startups (3567)
United States (17395)
Vaccines (595)
Weight loss (201)
Date
Today (147)
Last 7 days (611)
Last 30 days (2810)
Last 365 days (34749)
2025 (2923)
2024 (35217)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46543)
2018 (35020)
2017 (32109)
2016 (31481)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28571)
2011 (29264)
2010 (27328)
Location
Africa (714)
Arizona (206)
Asia (37441)
Australia (6119)
California (4446)
Canada (1621)
China (371)
Colorado (202)
Connecticut (211)
Europe (80221)
Florida (645)
Georgia (156)
Illinois (439)
Indiana (249)
Maryland (703)
Massachusetts (3426)
Michigan (190)
Minnesota (325)
New Jersey (1260)
New York (1279)
North Carolina (804)
Northern California (1941)
Ohio (164)
Pennsylvania (1039)
South America (1093)
Southern California (1679)
Texas (647)
Utah (131)
Washington State (440)
691,038 Results for "ecolab inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Ecolab Delivers Very Strong First Quarter Performance
Ecolab Delivers Very Strong First Quarter Performance.
April 30, 2024
·
30 min read
Press Releases
Medline completes successful acquisition of surgical solutions business from Ecolab Inc.
August 2, 2024
·
2 min read
Business
Ecolab Schedules Webcast and Conference Call on April 30th
Ecolab will host a live webcast of its first quarter earnings conference call to discuss 2024 first quarter results.
March 19, 2024
·
1 min read
Business
Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing
Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of Purolite’s DurA Cycle, a protein A chromatography resin for large-scale purification processes.
June 3, 2024
·
4 min read
Business
Baker to Retire From Ecolab Board
Ecolab announced that Douglas M. Baker, Jr., executive chairman of the board of directors of Ecolab, has informed the company that he will step down from the board following the expiration of his current term at Ecolab’s 2022 Annual Meeting of Shareholders on May 5, 2022.
February 28, 2022
·
2 min read
Deals
Ecolab Declares Regular Dividend
The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.51 per common share, to be paid April 15, 2022, to shareholders of record at the close of business on March 15, 2022.
February 24, 2022
·
1 min read
BioMidwest
Ecolab Life Sciences Announces 12% Price Increase
Ecolab Inc. will begin implementing a price increase for all Life Sciences division offerings, effective February 1, 2022, due to the significant and ongoing global supply chain disruptions and cost increases, including those for raw materials, logistics and labor.
January 21, 2022
·
2 min read
BioMidwest
Ecolab Announces a Temporary Global 8%-12% Energy Surcharge
Ecolab Inc. (NYSE:ECL) announced a temporary 8%-12% energy surcharge on all of its global products, effective April 1, 2022.
March 15, 2022
·
4 min read
BioMidwest
Ecolab Celebrates New Water Stewardship Certifications on World Water Day
Ecolab Inc. has increased its portfolio of Alliance for Water Stewardship (AWS) certified sites, adding two manufacturing plants in Lerma and Cuautitlan Izcalli, Mexico.
March 22, 2022
·
3 min read
Business
Ecolab Third Quarter Reported Diluted EPS $1.21; Adjusted Diluted EPS $1.30 With Double-Digit Growth in Sales and Pricing; Expect Continued Improvement in Fourth Quarter 2022 Performance
Ecolab Third Quarter Reported Diluted EPS $1.21; Adjusted Diluted EPS $1.30 With Double-Digit Growth in Sales and Pricing.
November 1, 2022
·
33 min read
1 of 69,104
Next
